KLHL40 and nemaline myopathy: In an era of new gene editing approaches and in times when finding therapies for rare inherited diseases is a health-related goal in Europe, the KLHL40-related nemaline myopathies may represent a good case for new examples of 1M1M development (https://www.1mutation1medicine.eu, accessed on 8 January 2024).